Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Assessment of Sunitinib-Induced Toxicities and Clinical Outcomes Based on Therapeutic Drug Monitoring of Sunitinib for Patients With Renal Cell Carcinoma

Published:2015-08 Issue:4 Volume:13 Page:350-358
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Noda Satoshi,Otsuji Takashi,Baba Masato,Yoshida Tetsuya,Kageyama Susumu,Okamoto Keisei,Okada Yusaku,Kawauchi Akihiro,Onishi Hiroyuki,Hira Daiki,Morita Shin-ya,Terada Tomohiro^ORCID

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

2. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma;Flaig;Invest New Drugs,2009

3. Lung toxicity in a patient treated with sunitinib;Boyle;Eur Respir J,2012

4. Toxic dermatolysis, tissue necrosis and impaired wound healing due to sunitinib treatment leading to forefoot amputation;Feyerabend;Urol Int,2009

5. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review;de Jonge;Clin Pharmacokinet,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism;BMC Cancer;2024-09-11

2. Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-06

3. Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer;Clinical Genitourinary Cancer;2024-06

4. Sacubitril/valsartan alleviates sunitinib-induced cardiac fibrosis and oxidative stress via improving TXNIP/TRX system and downregulation of NF-ĸB/Wnt/β-catenin/SOX9 signaling;International Immunopharmacology;2024-05

5. Management of high-alert medications by clinical pharmacological approaches;Folia Pharmacologica Japonica;2024-03-01